How Undetected IP Theft Quietly Hurts Biotech Valuation
Biotech valuation is built on confidence, and that confidence is in data integrity, proprietary advantage, and defensible intellectual property. Yet one of the most underestimated threats to that valuation rarely appears in financial models or board decks: undetected IP exposure hidden inside everyday operations. The most damaging IP theft events don’t involve ransomware or system […]
The Silent Gap Exposing Biotech IP
Most biotech leaders believe breaches originate in data centers or cloud platforms. In reality, many begin on endpoints, executive laptops, researcher systems, remote devices, or contractor machines that quietly bypass traditional controls. When no unified EDR or MDR exists, leadership loses its early-warning system. And without early warning, response becomes reactive, expensive, and the potential […]